Table 2.
Treatments approaches of ORN used in the last 10 years.
| Authors/date | n | Successful treatments | Follow-up (months) |
|---|---|---|---|
| D'Souza et al. (2007)24 | 23 | 3 HBO | 30 (minimum) |
| 3 HBO, S | |||
| 5 S | |||
| Coletti and Ord (2008)27 | 19 | 5 S | 18 (mean) |
| Alam et al. (2009)23 | 33 | 8 ATB, HBO, S | 1–61 |
| 22 ATB, S | |||
| Lee et al. (2009)28 | 13 | 2 S | 6–361 |
| 3 HBO, S | |||
| Oh et al. (2009)29 | 114 | 4 ATB, HBO | 12–382 |
| 7 ATB, S | |||
| 18 ATB, NSD | |||
| 25 ATB, HBO, NSD | |||
| 34 ATB, HBO, S | |||
| Delanian et al. (2011)30 | 54 | 16 ATB, PENTOCLO | 2–36 |
| Hampson et al. (2012)31 | 411 | 243 HBO | 96 |
| Mücke et al. (2013)32 | 94 | 44 ATB, S | 12 (minimum) |
| Niewald et al. (2013)33 | 11 | 1 HBO | 1–147 |
| 2 NSD | |||
| 5 S | |||
| Lyons et al. (2014)34 | 85 | 3 ATB, PENTO, DNS | 3–60 |
| 4 ATB, PENTOCLO | |||
| 14 ATB, PENTO | |||
| 35 ATB, PENTO, S | |||
| Porcaro et al. (2015)35 | 01 | 1 ATB, NSD | 12 |
| Raguse et al. (2016)36 | 149 | 2 ATB | 27–54 |
| 6 S | |||
| 30 NSD |
ATB, antibiotic therapy; S, surgery; NSD, non-surgical debridement; PENTO, pentoxifylline and tocopherol; PENTOCLO, pentoxifylline, tocoferol and clodronate; HBO, hyperbaric oxygenation.